Clearance came after an investigational device exemption study of 135 patients in four countries, including the U.S.
The Pod aims to be an improved vertebral fracture repair device.
More Articles on Supply Chain:
K2M Spinal Deformity Device Implanted in First French Hospital Procedure
Vivex Biomedical Raises $7.4M for Stem Cell, Implant Technologies
Alphatec Holdings to Reduce Workforce, Operating Expenses for French Affiliate
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
